These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinic. Chatenoud L; Waldmann H Rev Diabet Stud; 2012; 9(4):372-81. PubMed ID: 23804274 [TBL] [Abstract][Full Text] [Related]
8. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells. Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522 [TBL] [Abstract][Full Text] [Related]
9. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845 [TBL] [Abstract][Full Text] [Related]
10. Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice. Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y Am J Pathol; 2008 Apr; 172(4):972-9. PubMed ID: 18349126 [TBL] [Abstract][Full Text] [Related]
11. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846 [TBL] [Abstract][Full Text] [Related]
12. Long-term correction of hyperglycemia in diabetic mice after implantation of cultured human cells derived from fetal pancreas. Wu F; Jagir M; Powell JS Pancreas; 2004 Jul; 29(1):e23-9. PubMed ID: 15211120 [TBL] [Abstract][Full Text] [Related]
15. Organogenesis of pancreatic anlagen allografted in rats. Wang L; Huang YB; Chen G; Wang SS; Xie L; Zeng MH; Li R; Chen S Transplant Proc; 2006 Dec; 38(10):3280-2. PubMed ID: 17175249 [TBL] [Abstract][Full Text] [Related]
16. Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice. Ding L; Gysemans CA; Stangé G; Heremans Y; Yuchi Y; Takiishi T; Korf H; Chintinne M; Carr RD; Heimberg H; Pipeleers D; Mathieu C PLoS One; 2014; 9(9):e107935. PubMed ID: 25268801 [TBL] [Abstract][Full Text] [Related]
17. Reversal of New Onset Type 1 Diabetes by Oral Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI Front Immunol; 2019; 10():320. PubMed ID: 30863412 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD3/Anti-CXCL10 Antibody Combination Therapy Induces a Persistent Remission of Type 1 Diabetes in Two Mouse Models. Lasch S; Müller P; Bayer M; Pfeilschifter JM; Luster AD; Hintermann E; Christen U Diabetes; 2015 Dec; 64(12):4198-211. PubMed ID: 26293506 [TBL] [Abstract][Full Text] [Related]
19. Anti-CD43 monoclonal antibody L11 blocks migration of T cells to inflamed pancreatic islets and prevents development of diabetes in nonobese diabetic mice. Johnson GG; Mikulowska A; Butcher EC; McEvoy LM; Michie SA J Immunol; 1999 Nov; 163(10):5678-85. PubMed ID: 10553098 [TBL] [Abstract][Full Text] [Related]
20. Cytokines and autoimmune beta cell destruction in NOD mouse fetal pancreas isografts in cyclophosphamide-induced diabetes. Kovarik J; Faulkner-Jones BE; Koulmanda M; Mandel TE Autoimmunity; 1997; 26(4):245-52. PubMed ID: 9543185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]